Magseed (Endomag) is a marker that commonly used for localising impalpable breast lesions. It is a small single-use metal device (seed) designed to accurately mark the site of a breast cancer lesion ...

Oct. 22—FAIRFIELD — When it comes to finding and treating breast cancer, Dr. Scott Stoeger believes his role comes down to one premise. "The ultimate goal is to be minimally invasive," he said. Indeed ...

A new and more accurate option in breast cancer surgery called Magseed is giving women better outcomes, with fewer needing repeat surgeries because their cancer wasn't completely removed. Before a ...

CAMBRIDGE, England--(BUSINESS WIRE)--Endomag, the surgical guidance company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the ...

For nearly 50 years, patients with breast cancer requiring a lumpectomy have undergone a multi-step process on the day of surgery. To locate the site of a tumor, the first step has been a procedure ...

Breast cancer patients in the Midland now have access to a new option when preparing for breast cancer surgery. Magseed, offered at MidMichigan Medical Center – Midland, is a simpler, more effective ...

A Toowoomba private hospital is leading the way in breast cancer surgery, with a simpler, less painful and more accurate way of locating and removing breast cancer. The new magnetic technology of ...

ST. LOUIS, MO — There is some amazing new technology to streamline breast cancer treatment for some patients. SSM Health Saint Louis University Hospital is among the first in the region using a new ...

CAMBRIDGE, England & SAN FRANCISCO--(BUSINESS WIRE)--Endomag, the cancer healthcare company, announced today that the University of California, San Francisco (UCSF) has become the first US site to ...

Endomag, the surgical guidance company, announced that it has received CE Mark approval for Magseed, a minimally invasive breast marker used to accurately guide surgeons during breast cancer removal.

A literature search was carried out for this briefing in accordance with NICE's interim process and methods statement for the production of medtech innovation briefings. This briefing includes the ...

While some breast tumors are easy to feel, up to 50 percent are too small to feel by hand. To remove the cancer as accurately as possible, localizing it in the breast is very important. In the past, ...